These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34355840)

  • 1. Early Divergence in Misfolding Pathways of Amyloid-Beta Peptides.
    Mamone S; Glöggler S; Becker S; Rezaei-Ghaleh N
    Chemphyschem; 2021 Nov; 22(21):2158-2163. PubMed ID: 34355840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aβ monomers transiently sample oligomer and fibril-like configurations: ensemble characterization using a combined MD/NMR approach.
    Rosenman DJ; Connors CR; Chen W; Wang C; García AE
    J Mol Biol; 2013 Sep; 425(18):3338-59. PubMed ID: 23811057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution NMR studies of Aβ monomer dynamics.
    Wang C
    Protein Pept Lett; 2011 Apr; 18(4):354-61. PubMed ID: 21222639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
    Lam AR; Teplow DB; Stanley HE; Urbanc B
    J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and γ-secretase processing of the C99 peptide.
    Tang TC; Kienlen-Campard P; Hu Y; Perrin F; Opsomer R; Octave JN; Constantinescu SN; Smith SO
    J Biol Chem; 2019 Apr; 294(15):5854-5866. PubMed ID: 30755484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing amyloid-beta protein misfolding from molecular dynamics simulations with explicit water.
    Lee C; Ham S
    J Comput Chem; 2011 Jan; 32(2):349-55. PubMed ID: 20734314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.
    Xiao Y; Matsuda I; Inoue M; Sasahara T; Hoshi M; Ishii Y
    J Biol Chem; 2020 Jan; 295(2):458-467. PubMed ID: 31771980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.
    Yan Y; Wang C
    J Mol Biol; 2006 Dec; 364(5):853-62. PubMed ID: 17046788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the structural and thermodynamic properties of Aβ42 and Aβ40.
    Lin Y; Im H; Diem LT; Ham S
    Biochem Biophys Res Commun; 2019 Mar; 510(3):442-448. PubMed ID: 30722990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: a combined MD / NMR study.
    Sgourakis NG; Yan Y; McCallum SA; Wang C; Garcia AE
    J Mol Biol; 2007 May; 368(5):1448-57. PubMed ID: 17397862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hexameric peptide barrel as building block of amyloid-β protofibrils.
    Lendel C; Bjerring M; Dubnovitsky A; Kelly RT; Filippov A; Antzutkin ON; Nielsen NC; Härd T
    Angew Chem Int Ed Engl; 2014 Nov; 53(47):12756-60. PubMed ID: 25256598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
    Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
    J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-Molecule Targeted Aβ
    Mei J; Yang H; Sun B; Liu C; Ai H
    ACS Chem Neurosci; 2021 Apr; 12(7):1197-1209. PubMed ID: 33687193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of K16A and K28A mutation on the structure and dynamics of amyloid-β
    Shuaib S; Saini RK; Goyal D; Goyal B
    J Biomol Struct Dyn; 2020 Feb; 38(3):708-721. PubMed ID: 30821624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico study of amyloid beta-protein folding and oligomerization.
    Urbanc B; Cruz L; Yun S; Buldyrev SV; Bitan G; Teplow DB; Stanley HE
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17345-50. PubMed ID: 15583128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
    Dong M; Zhao W; Hu D; Ai H; Kang B
    ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.
    Sato T; Kienlen-Campard P; Ahmed M; Liu W; Li H; Elliott JI; Aimoto S; Constantinescu SN; Octave JN; Smith SO
    Biochemistry; 2006 May; 45(17):5503-16. PubMed ID: 16634632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.